{"id":3233,"date":"2018-01-22T15:52:04","date_gmt":"2018-01-22T13:52:04","guid":{"rendered":"https:\/\/www.psobest.de\/?page_id=3233"},"modified":"2026-10-13T11:51:47","modified_gmt":"2026-10-13T09:51:47","slug":"registration-frequencies-2","status":"publish","type":"page","link":"https:\/\/www.psobest.de\/en\/registration-frequencies-2\/","title":{"rendered":"Registration Frequencies"},"content":{"rendered":"<p>Weekly updated frequencies of observation starts at registration by medication are shown.<\/p>\n<p><strong>Fig 1) Patient numbers by biologic treatment at inclusion <\/strong><br \/>\nLast update: 13. October | total n= 28,010<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-full wp-image-3522\" src=\"https:\/\/www.psobest.de\/wp-content\/uploads\/2025\/04\/Fig1-24.png\" alt=\"Fig 1) Patient numbers by biologic treatment at inclusion\" width=\"587\" height=\"438\" \/><\/p>\n<p>&nbsp;<\/p>\n<p><strong>Fig 2) PsoBest registry: patient numbers by non-biologic treatment at inclusion<\/strong><br \/>\nLast update: 13. October | total n= 28,010<br \/>\n<img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-full wp-image-3524\" src=\"https:\/\/www.psobest.de\/wp-content\/uploads\/2026\/05\/Fig2-25.png\" alt=\"Fig 2) PsoBest registry: patient numbers by non-biologic treatment at inclusion\" width=\"587\" height=\"223\" \/><\/p>\n<p>&nbsp;<\/p>\n<div id=\"akkordeon\">\n<p><a class=\"show\" href=\"#akkordeon\">Show table for Fig. 1\/2<\/a><a class=\"hide\" href=\"#\">Hide table<\/a><\/p>\n<div class=\"inhalt\">\n<table>\n<tbody>\n<tr>\n<th>Inclusion Treatment<\/th>\n<th>Patient Number<\/th>\n<th>of that with similar agents (e.g. Biosimilars)<\/th>\n<\/tr>\n<tr>\n<td>Adalimumab<\/td>\n<td>1100<\/td>\n<td>1697<\/td>\n<\/tr>\n<tr>\n<td>Bimekizumab<\/td>\n<td>534<\/td>\n<td>0<\/td>\n<\/tr>\n<tr>\n<td>Brodalumab<\/td>\n<td>612<\/td>\n<td>0<\/td>\n<\/tr>\n<tr>\n<td>Certolizumab<\/td>\n<td>255<\/td>\n<td>0<\/td>\n<\/tr>\n<tr>\n<td>Efalizumab<\/td>\n<td>35<\/td>\n<td>0<\/td>\n<\/tr>\n<tr>\n<td>Etanercept<\/td>\n<td>312<\/td>\n<td>72<\/td>\n<\/tr>\n<tr>\n<td>Golimumab<\/td>\n<td>25<\/td>\n<td>0<\/td>\n<\/tr>\n<tr>\n<td>Guselkumab<\/td>\n<td>2341<\/td>\n<td>0<\/td>\n<\/tr>\n<tr>\n<td>Infliximab<\/td>\n<td>102<\/td>\n<td>1<\/td>\n<\/tr>\n<tr>\n<td>Ixekizumab<\/td>\n<td>1178<\/td>\n<td>0<\/td>\n<\/tr>\n<tr>\n<td>Risankizumab<\/td>\n<td>2416<\/td>\n<td>0<\/td>\n<\/tr>\n<tr>\n<td>Secukinumab<\/td>\n<td>2316<\/td>\n<td>0<\/td>\n<\/tr>\n<tr>\n<td>Tildrakizumab<\/td>\n<td>2030<\/td>\n<td>0<\/td>\n<\/tr>\n<tr>\n<td>Ustekinumab<\/td>\n<td>785<\/td>\n<td>79<\/td>\n<\/tr>\n<tr>\n<td>Apremilast<\/td>\n<td>815<\/td>\n<td>0<\/td>\n<\/tr>\n<tr>\n<td>Ciclosporin<\/td>\n<td>402<\/td>\n<td>0<\/td>\n<\/tr>\n<tr>\n<td>Deucravacitinib<\/td>\n<td>336<\/td>\n<td>0<\/td>\n<\/tr>\n<tr>\n<td>Fumaric acid esters<\/td>\n<td>2694<\/td>\n<td>0<\/td>\n<\/tr>\n<tr>\n<td>Dimethyl fumarate<\/td>\n<td>3582<\/td>\n<td>0<\/td>\n<\/tr>\n<tr>\n<td>Methotrexate<\/td>\n<td>3924<\/td>\n<td>0<\/td>\n<\/tr>\n<tr>\n<td>Tofacitinib<\/td>\n<td>2<\/td>\n<td>0<\/td>\n<\/tr>\n<tr>\n<td>Upadacitinib<\/td>\n<td>9<\/td>\n<td>0<\/td>\n<\/tr>\n<tr>\n<td>other systemics<\/td>\n<td>356<\/td>\n<td>0<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<\/div>\n<p>&nbsp;<\/p>\n<p><strong>Fig. 3) Rate of patients by medication class at inclusion<\/strong><br \/>\nLast update: 13. October | total n= 28,010<br \/>\n<a href=\"https:\/\/www.psobest.de\/wp-content\/uploads\/2026\/10\/Fig3.png\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone wp-image-6221\" src=\"https:\/\/www.psobest.de\/wp-content\/uploads\/2026\/10\/Fig3-300x216.png\" alt=\"\" width=\"587\" height=\"423\" srcset=\"https:\/\/www.psobest.de\/wp-content\/uploads\/2026\/10\/Fig3-300x216.png 300w, https:\/\/www.psobest.de\/wp-content\/uploads\/2026\/10\/Fig3.png 753w\" sizes=\"(max-width: 587px) 100vw, 587px\" \/><\/a><\/p>\n<p>&nbsp;<\/p>\n<p><strong>Fig. 4) Rate of patients by type of registry site<\/strong><br \/>\nLast update: 13. October | total n= 28,010<br \/>\n<a href=\"https:\/\/www.psobest.de\/wp-content\/uploads\/2026\/10\/Figure4.png\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone  wp-image-6225\" src=\"https:\/\/www.psobest.de\/wp-content\/uploads\/2026\/10\/Figure4-300x217.png\" alt=\"\" width=\"588\" height=\"425\" srcset=\"https:\/\/www.psobest.de\/wp-content\/uploads\/2026\/10\/Figure4-300x217.png 300w, https:\/\/www.psobest.de\/wp-content\/uploads\/2026\/10\/Figure4.png 750w\" sizes=\"(max-width: 588px) 100vw, 588px\" \/><\/a><\/p>\n<p>&nbsp;<\/p>\n<p><strong>Fig. 5) Registered PsoBest centers<\/strong><br \/>\nLast update: 13. October| n=<span id=\"AnzahlMonat\"><\/span> 1,214 | <strong>updated monthly<\/strong><br \/>\n<img loading=\"lazy\" decoding=\"async\" class=\"alignnone  wp-image-3530\" src=\"https:\/\/www.psobest.de\/wp-content\/uploads\/2018\/07\/Fig5.png\" alt=\"Fig. 5) Registered PsoBest centers\" width=\"587\" height=\"430\" srcset=\"https:\/\/www.psobest.de\/wp-content\/uploads\/2018\/07\/Fig5.png 750w, https:\/\/www.psobest.de\/wp-content\/uploads\/2018\/07\/Fig5-300x220.png 300w\" sizes=\"(max-width: 587px) 100vw, 587px\" \/><\/p>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Weekly updated frequencies of observation starts at registration by medication are shown. Fig 1) Patient numbers by biologic treatment at inclusion Last update: 13. October | total n= 28,010 &nbsp; Fig 2) PsoBest registry: patient numbers by non-biologic treatment at inclusion Last update: 13. October | total n= 28,010 &nbsp; Show table for Fig. 1\/2Hide [&hellip;]<\/p>\n","protected":false},"author":4,"featured_media":0,"parent":0,"menu_order":10,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.2 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Registration Frequencies - PsoBest<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.psobest.de\/en\/registration-frequencies-2\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Registration Frequencies - PsoBest\" \/>\n<meta property=\"og:description\" content=\"Weekly updated frequencies of observation starts at registration by medication are shown. Fig 1) Patient numbers by biologic treatment at inclusion Last update: 13. October | total n= 28,010 &nbsp; Fig 2) PsoBest registry: patient numbers by non-biologic treatment at inclusion Last update: 13. October | total n= 28,010 &nbsp; Show table for Fig. 1\/2Hide [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.psobest.de\/en\/registration-frequencies-2\/\" \/>\n<meta property=\"og:site_name\" content=\"PsoBest\" \/>\n<meta property=\"article:modified_time\" content=\"2026-10-13T09:51:47+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.psobest.de\/wp-content\/uploads\/2025\/04\/Fig1-24.png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.psobest.de\/en\/registration-frequencies-2\/\",\"url\":\"https:\/\/www.psobest.de\/en\/registration-frequencies-2\/\",\"name\":\"Registration Frequencies - PsoBest\",\"isPartOf\":{\"@id\":\"https:\/\/www.psobest.de\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.psobest.de\/en\/registration-frequencies-2\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.psobest.de\/en\/registration-frequencies-2\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.psobest.de\/wp-content\/uploads\/2025\/04\/Fig1-24.png\",\"datePublished\":\"2018-01-22T13:52:04+00:00\",\"dateModified\":\"2026-10-13T09:51:47+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.psobest.de\/en\/registration-frequencies-2\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.psobest.de\/en\/registration-frequencies-2\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.psobest.de\/en\/registration-frequencies-2\/#primaryimage\",\"url\":\"https:\/\/www.psobest.de\/wp-content\/uploads\/2025\/04\/Fig1-24.png\",\"contentUrl\":\"https:\/\/www.psobest.de\/wp-content\/uploads\/2025\/04\/Fig1-24.png\",\"width\":753,\"height\":561},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.psobest.de\/en\/registration-frequencies-2\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\/\/www.psobest.de\/en\/welcome\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Registration Frequencies\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.psobest.de\/#website\",\"url\":\"https:\/\/www.psobest.de\/\",\"name\":\"PsoBest\",\"description\":\"The German Psoriasis-Registry.\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.psobest.de\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Registration Frequencies - PsoBest","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.psobest.de\/en\/registration-frequencies-2\/","og_locale":"en_US","og_type":"article","og_title":"Registration Frequencies - PsoBest","og_description":"Weekly updated frequencies of observation starts at registration by medication are shown. Fig 1) Patient numbers by biologic treatment at inclusion Last update: 13. October | total n= 28,010 &nbsp; Fig 2) PsoBest registry: patient numbers by non-biologic treatment at inclusion Last update: 13. October | total n= 28,010 &nbsp; Show table for Fig. 1\/2Hide [&hellip;]","og_url":"https:\/\/www.psobest.de\/en\/registration-frequencies-2\/","og_site_name":"PsoBest","article_modified_time":"2026-10-13T09:51:47+00:00","og_image":[{"url":"https:\/\/www.psobest.de\/wp-content\/uploads\/2025\/04\/Fig1-24.png"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.psobest.de\/en\/registration-frequencies-2\/","url":"https:\/\/www.psobest.de\/en\/registration-frequencies-2\/","name":"Registration Frequencies - PsoBest","isPartOf":{"@id":"https:\/\/www.psobest.de\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.psobest.de\/en\/registration-frequencies-2\/#primaryimage"},"image":{"@id":"https:\/\/www.psobest.de\/en\/registration-frequencies-2\/#primaryimage"},"thumbnailUrl":"https:\/\/www.psobest.de\/wp-content\/uploads\/2025\/04\/Fig1-24.png","datePublished":"2018-01-22T13:52:04+00:00","dateModified":"2026-10-13T09:51:47+00:00","breadcrumb":{"@id":"https:\/\/www.psobest.de\/en\/registration-frequencies-2\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.psobest.de\/en\/registration-frequencies-2\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.psobest.de\/en\/registration-frequencies-2\/#primaryimage","url":"https:\/\/www.psobest.de\/wp-content\/uploads\/2025\/04\/Fig1-24.png","contentUrl":"https:\/\/www.psobest.de\/wp-content\/uploads\/2025\/04\/Fig1-24.png","width":753,"height":561},{"@type":"BreadcrumbList","@id":"https:\/\/www.psobest.de\/en\/registration-frequencies-2\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/www.psobest.de\/en\/welcome\/"},{"@type":"ListItem","position":2,"name":"Registration Frequencies"}]},{"@type":"WebSite","@id":"https:\/\/www.psobest.de\/#website","url":"https:\/\/www.psobest.de\/","name":"PsoBest","description":"The German Psoriasis-Registry.","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.psobest.de\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/www.psobest.de\/en\/wp-json\/wp\/v2\/pages\/3233\/"}],"collection":[{"href":"https:\/\/www.psobest.de\/en\/wp-json\/wp\/v2\/pages\/"}],"about":[{"href":"https:\/\/www.psobest.de\/en\/wp-json\/wp\/v2\/types\/page\/"}],"author":[{"embeddable":true,"href":"https:\/\/www.psobest.de\/en\/wp-json\/wp\/v2\/users\/4\/"}],"replies":[{"embeddable":true,"href":"https:\/\/www.psobest.de\/en\/wp-json\/wp\/v2\/comments\/?post=3233"}],"version-history":[{"count":487,"href":"https:\/\/www.psobest.de\/en\/wp-json\/wp\/v2\/pages\/3233\/revisions\/"}],"predecessor-version":[{"id":6226,"href":"https:\/\/www.psobest.de\/en\/wp-json\/wp\/v2\/pages\/3233\/revisions\/6226\/"}],"wp:attachment":[{"href":"https:\/\/www.psobest.de\/en\/wp-json\/wp\/v2\/media\/?parent=3233"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}